Determination of ReQuest™-based symptom thresholds to define symptom relief in GERD clinical studies

Digestion

Volumn 71, Issue 3, 2005, Pages 145-151

  Stanghellini, Vincenzo ^a   Armstrong, David ^b   Mönnikes, Hubert ^c   Berghöfer, Peter ^d   Gatz, Gudrun ^d   Bardhan, Karna Dev ^e  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b MCMASTER UNIVERSITY   (Canada)

^c HUMBOLDT UNIVERSITY   (Germany)

^d ALTANA PHARMA AG   (Germany)

^e ROTHERHAM GENERAL HOSPITAL   (United Kingdom)

Author keywords

Gastroesophageal reflux disease; Gastrointestinal Symptom Rating Scale; Psychological General Well Being scale; Reflux questionnaire; ReQuest ; Symptom evaluation, GERD related; Symptom thresholds, GERD

Indexed keywords

ADULT; ARTICLE; CLINICAL STUDY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EVALUATION; FEMALE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL SYMPTOM; HUMAN; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL ANALYSIS; NORMAL HUMAN; PRIORITY JOURNAL; QUESTIONNAIRE; RATING SCALE; SCORING SYSTEM; SLEEP DISORDER; WELLBEING; COMPARATIVE STUDY; FOLLOW UP; GERMANY; HOSPITALIZATION; NONPARAMETRIC TEST; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; REPRODUCIBILITY; STANDARD;

ADULT; FEMALE; FOLLOW-UP STUDIES; GASTROESOPHAGEAL REFLUX; GERMANY; HUMANS; MALE; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC;

EID: 21344465867     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000085564     Document Type: Article

References (19)

1. Guedon C: How to diagnose gastroesophageal reflux? Part 1. Diagnostic value of symptoms. Interpretation and role of endoscopy (in French). Gastroenterol Clin Biol 1999;23: S202-S207.
2. Wiklund IK, Glise H: Quality of life in different gastrointestinal conditions. Eur J Surg 1998;582(suppl):56-61.
3. Dent J, Brun J, Fendrick AM, Fennerty MB, Janssens J, Kahrilas PJ, Lauritsen K, Reynolds JC, Shaw M, Talley NJ, on the behalf of the Genval Workshop Group: An evidence-based appraisal of reflux disease management - The Genval Workshop Report. Gut 1999;44(suppl 2):S1-S16.
4. Moss SF, Armstrong D, Arnold R, Ferenci P, Fock KM, Holtmann G, McCarthy DM, Moraes-Filho JP, Mutschler E, Playford R, Spechler SJ, Stanghellini V, Modlin IM: GERD 2003 - A consensus on the way ahead. Digestion 2003;67:111-117.
5. Stanghellini V, Armstrong D, Mönnikes H, Bardhan KD: Systematic review: Do we need a new gastro-oesophageal reflux disease questionnaire? Aliment Pharmacol Ther 2004;19: 463-479.
6. Armstrong D, Mönnikes H, Bardhan KD, Stanghellini V: The construction of a new evaluative GERD questionnaire - Methods and state of the art. Digestion 2004;70:71-78.
7. Bardhan KD, Stanghellini V, Armstrong D, Berghöfer P, Gatz G, Mönnikes H: Evaluation of GERD symptoms during therapy. Part I. Development of the new GERD questionnaire ReQuest™. Digestion 2004;69:229-237.
8. Mönnikes H, Bardhan KD, Stanghellini V, Berghöfer P, Bethke TD, Armstrong D: Evaluation of GERD symptoms during therapy. Part II. Psychometric evaluation and validation of the new questionnaire ReQuest™ in erosive GERD. Digestion 2004;69:238-244.
9. Bardhan KD, Stanghellini V, Armstrong D, Berghöfer P, Gatz G, Mönnikes H: International validation of ReQuest™ in patients with endoscopy negative gastroesophageal reflux disease. Aliment Pharmacol Ther 2004;20: 891-898.
10. Castell DO, Kahrilas PJ, Richter JE, Vakil NB, Johnson DA, Zuckermann S, Skammer W, Levine JG: Esomeprazole (40 mg) compared with lansoprazole (30 mg) in the treatment of erosive esophagitis. Am J Gastroenterol 2002; 97:575-583.
11. Talley NJ, Lauritsen K, Tunturi-Hihnala H, Lind T, Moum B, Bang C, Schulz T, Omland TM, Delle M, Junghard O: Esomeprazole 20 mg maintains symptom control in endoscopy-negative gastro-oesophageal reflux disease: A controlled trial of 'on-demand' therapy for 6 months. Aliment Pharmacol Ther 2001; 15:347-354.
12. Dettmer A, Vogt R, Sielaff F, Luhmann R, Schneider A, Fischer R: Pantoprazole 20 mg is effective for relief of symptoms and healing of lesions in mild reflux oesophagitis. Aliment Pharmacol Ther 1998;12:865-872.
13. Hatlebakk JG, Hyggen A, Madsen PH, Walle PO, Schulz T, Mowinckel P, Bernklev T, Berstad A, on behalf of the Norwegian Heartburn Study Group: Heartburn treatment in primary care: Randomised, double blind study for 8 weeks. BMJ 1999;319:550-553.
14. Mathus-Vliegen EM, Tytgat GN: Gastroesophageal reflux in obese subjects: Influence of overweight, weight loss and chronic gastric balloon distension. Scand J Gastroenterol 2002;37:1246-1252.
15. Ter RB, Johnston BT, Castell DO: Influence of age and gender on gastroesophageal reflux in symptomatic patients. Dis Esophagus 1998; 11:106-108.
16. Sharma N, Donnellan C, Preston C, Delaney B, Duckett G, Moayyedi P: A systematic review of symptomatic outcomes used in oesophagitis drug therapy trials. Gut 2004;53(suppl 4):58-65.
17. Enck P, Dubois D, Marquis P: Quality of life in patients with upper gastrointestinal symptoms: Results from the Domestic/International Gastroenterology Surveillance Study (DIGEST). Scand J Gastroenterol 1999;231(suppl):48-54.
18. Dimenas E, Carlsson G, Glise H, Israelsson B, Wiklund I: Relevance of norm values as part of the documentation of quality of life instruments for use in upper gastrointestinal disease. Scand J Gastroenterol Suppl 1996;221:8-13.
19. Huang JQ, Hunt RH: pH, healing rate and symptom relief in patients with GERD. Yale J Biol Med 1999;72:181-194.